Jose Juan Escobar-Barranco

KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema.

David M. Brown, Andrés Emanuelli, Francesco Bandello et al. · Bern Open Repository and Information System (University of Bern) · 2022 · 145 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

Use of intravitreal dexamethasone implants in the treatment of diabetic macular edema: Expert recommendations using a Delphi approach

Alfredo García‐Layana, Alfredo Adán, Francisco J. Ascaso et al. · European Journal of Ophthalmology · 2019 · 30 citations

Medicine, Ophthalmology, Surgery +16

Artificial intelligence-based fluid quantification and associated visual outcomes in a real-world, multicentre neovascular age-related macular degeneration national database

Rubén Martín, Jordi Izquierdo-Serra, Sandro De Zanet et al. · British Journal of Ophthalmology · 2023 · 25 citations

Medicine, Ophthalmology, Vision Science +17

Reasons for Delayed Anti-VEGF Treatment During COVID-19 Lockdown and Clinical Impact in Neovascular Age-Related Macular Degeneration

Javier Zarranz‐Ventura, Jose Juan Escobar-Barranco, Laia Gómez‐Baldó et al. · Ophthalmology and Therapy · 2023 · 10 citations · Full text

Medicine, Ophthalmology, Vision Science +17